Related Experiment Videos
[Sentinel lymph node biopsy in colorectal carcinoma]
A Bembenek1, S Gretschel, C Ulmer
1Klinik für Chirurgie und Chirurgische Onkologie, Charité-Universitätsmedizin Berlin, Campus Berlin-Buch, Robert-Rössle-Klinik im HELIOS-Klinikum Berlin, Berlin.
Summary
Sentinel lymph node biopsy (SLNB) may improve colon and rectal cancer staging by detecting micrometastases. This could impact adjuvant therapy decisions and potentially avoid extensive surgery for early-stage cancers.
Area of Science:
- Oncology
- Surgical Pathology
- Gastrointestinal Cancer Research
Background:
- Lymph node status is a critical prognostic factor in colon and rectal cancer.
- Accurate assessment is challenged by variations in lymph node selection, number examined, and histopathological quality.
- Sentinel lymph node biopsy (SLNB) is being investigated to enhance nodal status determination.
Purpose of the Study:
- To evaluate the clinical value of SLNB in improving the accuracy of nodal status assessment in colon and rectal cancer.
- To explore the potential of SLNB in identifying patients with micrometastases or isolated tumor cells.
- To assess the potential role of SLNB in guiding adjuvant therapy and in managing early-stage cancers.
Main Methods:
- Review of worldwide data from approximately 20 studies involving 800-1000 patients, primarily focusing on colon cancer.
- Intensified histopathological workup of sentinel lymph nodes (SLNs) following initial H&E staining.
- Investigation of SLNB for patients initially classified as node-negative.
Main Results:
- SLNB shows potential value for patients initially node-negative by H&E staining but found to have micrometastases or isolated tumor cells in SLNs.
- Data is currently derived from relatively small studies, with a focus on colon rather than rectal cancer.
- Further studies are needed to confirm the benefit of adjuvant therapy for patients identified through SLNB.
Conclusions:
- SLNB may significantly impact the therapy and prognosis of colon cancer patients if further studies confirm benefits from adjuvant therapy.
- SLNB could offer an alternative for determining nodal status after endoscopic excision of early cancer, potentially avoiding bowel resection and lymphonodectomy.